Show simple item record

dc.contributor.advisorErnest Fraenkel.en_US
dc.contributor.authorNg, Christopher Wen_US
dc.contributor.otherMassachusetts Institute of Technology. Department of Biological Engineering.en_US
dc.date.accessioned2015-07-31T19:10:35Z
dc.date.available2015-07-31T19:10:35Z
dc.date.copyright2015en_US
dc.date.issued2015en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/97978
dc.descriptionThesis: Sc. D., Massachusetts Institute of Technology, Department of Biological Engineering, 2015.en_US
dc.descriptionCataloged from PDF version of thesis.en_US
dc.descriptionIncludes bibliographical references (pages 157-192).en_US
dc.description.abstractUnlike the genomic sequence, the epigenome is dynamic, responding to and influencing the cellular state. Understanding the ways in which chromatin structure exercises control over transcriptional programs during development as well as aberrant gene expression signatures in human disease is a central challenge to biology and pathology. Despite the advance of tools to chart the chromatin landscape, much is still unknown about how epigenetic signals are integrated in the transcriptional outcome of a gene. Here, a number of systematic, genome-wide approaches result in the discovery of epigenetic patterns associated with the modulation of gene expression. We begin by examining Huntington's disease (HD), a fatal neurodegenerative disorder. The discovery of the genetic mutation that causes HD has led to the development of in-vitro and in-vivo models representative of the disease. Studies of these systems and patient samples have identified transcriptional dysregulation as a major component of the early stages of HD. Thus, HD serves as an ideal case in which to examine the modulation of gene expression in disease. First, we connect the changes in DNA methylation to the dynamics of gene expression and transcription factor binding in HD. We next identify a unique signature of the histone mark H3K4me3 at genes transcriptionally repressed in HD. Targeting this signature reverses the downregulation of genes and protects against neurodegeneration. Finally, we apply a novel, machine learning approach to 16 chromatin features in 44 human cell types. By globally examining the epigenetic states of genes in a variety of tissue contexts, we discover a small set of coordinated patterns that we term "epigenetic ensembles." Genes with particular ensembles are associated with changes in gene expression during differentiation and the control of cell-type-specific gene regulators such as super-enhancers, distal-enhancer-looping, nuclear lamina, and master transcription factors. Ensembles are also disproportionately affected in both HD and Alzheimer's disease. Together, this thesis presents a toolkit for recognizing and understanding epigenetic patterns that can further insight into the regulation of genes in development and disease.en_US
dc.description.statementofresponsibilityby Christopher W. Ng.en_US
dc.format.extent192 pagesen_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsMIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectBiological Engineering.en_US
dc.titleRecognizing epigenetic patterns that mark the control of cell state in differentiation and diseaseen_US
dc.typeThesisen_US
dc.description.degreeSc. D.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineering
dc.identifier.oclc914167659en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record